GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes

Nepton Soltani,Hongmin Qiu,Mila Aleksic,Yelena Glinka,Fang Zhao,Rui Liu,Yiming Li,Nina Zhang,Rabindranath Chakrabarti,Tiffany Ng,Tianru Jin,Haibo Zhang,Wei-Yang Lu,Zhong-Ping Feng,Gerald J. Prud'homme,Qinghua Wang

DOI: https://doi.org/10.1073/pnas.1102715108

IF: 11.1

2011-06-27

Proceedings of the National Academy of Sciences

Abstract:Type 1 diabetes (T1D) is an autoimmune disease characterized by insulitis and islet β-cell loss. Thus, an effective therapy may require β-cell restoration and immune suppression. Currently, there is no treatment that can achieve both goals efficiently. We report here that GABA exerts antidiabetic effects by acting on both the islet β-cells and immune system. Unlike in adult brain or islet α-cells in which GABA exerts hyperpolarizing effects, in islet β-cells, GABA produces membrane depolarization and Ca 2+ influx, leading to the activation of PI3-K/Akt–dependent growth and survival pathways. This provides a potential mechanism underlying our in vivo findings that GABA therapy preserves β-cell mass and prevents the development of T1D. Remarkably, in severely diabetic mice, GABA restores β-cell mass and reverses the disease. Furthermore, GABA suppresses insulitis and systemic inflammatory cytokine production. The β-cell regenerative and immunoinhibitory effects of GABA provide insights into the role of GABA in regulating islet cell function and glucose homeostasis, which may find clinical application.